Abstract
We have developed a genetic system, called degrakine, that specifically and stably inactivates chemokine receptors (CKR) by redirecting the ability of the HIV-1 protein, Vpu, to degrade CD4 in the endoplasmic reticulum (ER) via the host proteasome machinery. To harness Vpu's proteolytic targeting capability to degrade new receptors, we fused a chemokine with the C terminal region of Vpu. The fusion protein, or degrakine, accumulates in the ER, trapping and functionally inactivating its target CKR. We have demonstrated that degrakines based on SDF-1 (CXCL12), MDC (CCL22) and RANTES (CCL5) specifically inactivate their respective receptor functions. Using a retroviral vector expressing the SDF-1 degrakine, we have established that CXCR4 is required for the homing of hematopoietic stem/progenitor cells (HSPC) to the bone marrow immediately after transplantation. Thus the degrakine provides an effective genetic tool to dissect receptor functions in a number of biological systems in vitro and in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rossi, D. & Zlotnik, A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18, 217–242 (2000).
Yoshie, O., Imai, T. & Nomiyama, H. Chemokines in immunity. Adv. Immunol. 78, 57–110 (2001).
Sallusto, F., Mackay, C.R. & Lanzavecchia, A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu. Rev. Immunol. 18, 593–620 (2000).
Nelson, P.J. & Krensky, A.M. Chemokines, chemokine receptors, and allograft rejection. Immunity 14, 377–386 (2001).
Baggiolini, M. Chemokines and leukocyte traffic. Nature 392, 565–568 (1998).
Marsal, J. et al. Involvement of CCL25 (TECK) in the generation of the murine small-intestinal CD8α α+ CD3+ intraepithelial lymphocyte compartment. Eur. J. Immunol. 32, 3488–3497 (2002).
Chen, J.D., Bai, X., Yang, A.G., Cong, Y. & Chen, S.Y. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy. Nat. Med. 3, 1110–1116 (1997).
Engel, B.C. et al. Intrakines—evidence for a trans-cellular mechanism of action. Mol. Ther. 1, 165–170 (2000).
McManus, M.T. et al. Small interfering RNA-mediated gene silencing in T lymphocytes. J. Immunol. 169, 5754–5760 (2002).
McManus, M.T. & Sharp, P.A. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3, 737–747 (2002).
Cullen, B.R. RNA interference: antiviral defense and genetic tool. Nat. Immunol. 3, 597–599 (2002).
Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550–553 (2002).
Tiscornia, G., Singer, O., Ikawa, M. & Verma, I.M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. USA 27, 27 (2003).
Tortorella, D., Gewurz, B.E., Furman, M.H., Schust, D.J. & Ploegh, H.L. Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861–926 (2000).
Hirsch, C. & Ploegh, H.L. Intracellular targeting of the proteasome. Trends Cell Biol. 10, 268–272 (2000).
Margottin, F. et al. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell. 1, 565–574 (1998).
Willey, R.L., Maldarelli, F., Martin, M.A. & Strebel, K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66, 7193–7200 (1992).
Schubert, U. & Strebel, K. Differential activities of the human immunodeficiency virus type 1–encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68, 2260–2271 (1994).
Loetscher, M. et al. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem. 269, 232–237 (1994).
Bleul, C.C. et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829–833 (1996).
Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A. & Springer, T.A. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184, 1101–1109 (1996).
Oberlin, E. et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833–835 (1996).
Shirozu, M. et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28, 495–500 (1995).
Tashiro, K. et al. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261, 600–603 (1993).
Nagasawa, T. et al. Molecular cloning and characterization of a murine pre-B-cell growth–stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin. Proc. Natl. Acad. Sci. USA 93, 14726–14729 (1996).
Aiuti, A., Webb, I.J., Bleul, C., Springer, T. & Gutierrez-Ramos, J.C. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 185, 111–120 (1997).
Zou, Y.R., Kottmann, A.H., Kuroda, M., Taniuchi, I. & Littman, D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393, 595–599 (1998).
Kawabata, K. et al. A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution. Proc. Natl. Acad. Sci. USA 96, 5663–5667 (1999).
Peled, A. et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283, 845–848 (1999).
D'Apuzzo, M. et al. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur. J. Immunol. 27, 1788–1793 (1997).
Schols, D. et al. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J. Exp. Med. 186, 1383–1388 (1997).
Chantry, D. et al. Macrophage-derived chemokine is localized to thymic medullary epithelial cells and is a chemoattractant for CD3+, CD4+, CD8low thymocytes. Blood 94, 1890–1898 (1999).
Kim, C.H. & Broxmeyer, H.E. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 91, 100–110 (1998).
Wright, D.E., Bowman, E.P., Wagers, A.J., Butcher, E.C. & Weissman, I.L. Hematopoietic stem cells are uniquely selective in their migratory response to chemokines. J. Exp. Med. 195, 1145–1154 (2002).
Spangrude, G.J., Heimfeld, S. & Weissman, I.L. Purification and characterization of mouse hematopoietic stem cells. Science 241, 58–62 (1988).
Hardy, J. et al. Bioluminescence imaging of lymphocyte trafficking in vivo. Exp. Hematol. 29, 1353–1360 (2001).
Contag, P.R., Olomu, I.N., Stevenson, D.K. & Contag, C.H. Bioluminescent indicators in living mammals. Nat. Med. 4, 245–247 (1998).
Cheng, L. et al. Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny. Blood 92, 83–92 (1998).
Pear, W.S., Nolan, G.P., Scott, M.L. & Baltimore, D. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392–8396 (1993).
Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983).
Vilen, B.J., Burke, K.M., Sleater, M. & Cambier, J.C. Transmodulation of BCR signaling by transduction-incompetent antigen receptors: implications for impaired signaling in anergic B cells. J. Immunol. 168, 4344–4351 (2002).
Lapham, C.K., Zaitseva, M.B., Lee, S., Romanstseva, T. & Golding, H. Fusion of monocyctes and macrophages with HIV-1 correlates with biochemical properties of CXCR4 and CCR5. Nature 5, 303–308 (1999).
Szilvassy, S.J., Meyerrose, T.E., Ragland, P.L. & Grimes, B. Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood 98, 2108–2115 (2001).
Acknowledgements
We thank S. Chen, K. Strebel, H. Golding and M. Zaitseva for kindly providing the SDF-1 intrakine construct, the Vpu2/6 mutant, anti-CXCR4-4N and CXCR4 western protocol, respectively; J. Smith, Y. Kim, M. Townsend and A. Elms for technical assistance; E. Meissner and W. Helms for critical reading of the manuscript; R. Bagnell for assistance with confocal microscopy; and L. Arnold of the UNC Flow Cytometry Facility for assistance with FACS. Anti-Vpu and anti-CXCR4 (12G5) were obtained through the NIH AIDS Reagent program. The project was partially supported by grants from the US National Institutes of Health (nos. HL72240 and AI53804 to L.S.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Coffield, V., Jiang, Q. & Su, L. A genetic approach to inactivating chemokine receptors using a modified viral protein. Nat Biotechnol 21, 1321–1327 (2003). https://doi.org/10.1038/nbt889
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt889
This article is cited by
-
FoxP3 interacts with linker histone H1.5 to modulate gene expression and program Treg cell activity
Genes & Immunity (2011)
-
TSLP is involved in expansion of early thymocyte progenitors
BMC Immunology (2007)
-
Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP
BMC Immunology (2006)
-
The state of GPCR research in 2004
Nature Reviews Drug Discovery (2004)